The 4th World Congress on Interventional Therapies for Type 2 Diabetes is a comprehensive, multidisciplinary forum where clinicians, scientists, and policy makers will conduct a critical review and discussion of the latest research findings on metabolic/bariatric surgery and novel interventional therapies for type 2 diabetes. The first three editions were held with the participation of world leading experts, including Nobel Laureates, and with attendees from over 60 countries. The upcoming congress will build on the success of previous events, with a focus on providing access to cutting-edge treatment and moving forward From Guidelines to Implementation.

Major scientific organizations team up for a Joint Consensus Conference on Obesity Stigma at WCITD 2019 on April 10. People with obesity face not only increased risk of serious medical complications but also a pervasive, resilient form of social stigma. Weight bias undermines access to evidence-based treatments, misleads public health policies, confuses messages in popular media and compromises advances in research. Hence, tackling stigma is not only a matter of social justice but also a way to advance prevention and treatment of obesity and related diseases. A multidisciplinary group, including obesity researchers, clinicians, advocacy experts and other stakeholders will discuss the gap between scientific evidence and the myths and misconceptions that reinforce stigma.

Participate in this unprecedented initiative to address a major stumbling block in the fight against the pandemic of obesity and diabetes!

Meet our experienced and multidisciplinary faculty committed to making meaningful changes for
the future of diabetes